FindTrial
Sign In

The value of systemic immune-inflammation index(SII) in predicting the prognosis of patients with diquat poisoning

The value of systemic immune-inflammation index(SII) in predicting the prognosis of patients with diquat poisoning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068115
Enrollment
Unknown
Registered
2023-02-07
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diquat poisoning

Interventions

Death group and survival group:nothing

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)Age=14 years old (2)Poisoning patients with a clear history of oral diquat (3)Patients who receive regular diagnosis and treatment within 24 hours after taking medicine

Exclusion criteria

Exclusion criteria: (1) Those who have a history of serious heart, liver, kidney, lung, blood and autoimmune system diseases that affect the prognosis of this time (2) Complicated with infectious diseases (3) Combined with other poisons or drug poisoning (4) Incomplete information or missing visit

Design outcomes

Primary

MeasureTime frame
systemic immune-inflammation index;Neutrophil to lymphocyte ratio;Monocyte to lymphocyte ratio;Platelet to lymphocyte ratio;—

Countries

China

Contacts

Public ContactYan Xianliang

Affiliated Hospital of Xuzhou Medical University

docyxl@163.com18952159710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026